Study Type | Condition | Receptor Binding | C | Pu | NAc | GP | STN | SN | Reference |
---|---|---|---|---|---|---|---|---|---|
Acute Pain | Â | Â | Â | Â | Â | Â | Â | Â | Â |
 | Thermal Pain | Contact Heat (15)O-water |  | + |  |  |  |  | [161] |
 |  | Contact Heat (15)O-water |  | + |  |  |  |  | [162] |
 |  | Contact Heat (15)O-water |  | + |  |  |  |  | [163] |
 | Contact Heat (Pain Threshold) | Dopamine receptor binding (11C) Raclopride |  | Binding - inverse correlation to Heat thershold |  |  |  |  | [133] |
 | Muscle Pain Hypertonic Saline | (15)O-water |  | + |  |  |  |  | [164] |
 |  | Dopamine Receptor Binding (11C) Raclopride | + | + | + |  |  |  | [135] |
 | Visceral Pain | Gastric Distenton (15)O-water | + |  |  |  |  |  | [165] |
Placebo | Â | Â | Â | Â | Â | Â | Â | Â | Â |
 | Muscle Pain Hypertonic Saline | Opioid and Dopamine receptor binding Placebo (11C) Raclopride (11C) Carfentanil |  |  | Increased opioid and dopamine release |  |  |  | [65] |
 |  | Opioid and Dopamine receptor binding Placebo (11C) Raclopride (11C) Carfentanil |  |  | Decrease opioid and dopamine release |  |  |  | [65] |
Chronic Pain | Â | Â | Â | Â | Â | Â | Â | Â | Â |
 | Neuropathic Pain (Burning Mouth) | 6-[(18)F]fluorodopa |  | Decreased presynaptic dopamine function |  |  |  |  | [72] |
 | Neuropathic Pain | Motor Cortex Stimulation (15)O-water |  | + |  |  |  |  | [141] |
 | Atypical Facial Pain | Dopamine receptor binding [11C]raclopride |  | Increased D2 binding |  |  |  |  | [73] |
 | Fibromyalgia | μ receptor (11C) Carfentanil |  |  | Decreased Opioid Binding |  |  |  | [166] |
 |  | Dopamine receptor (11C) Raclopride |  |  | Decrease dopamine release |  |  |  | [74] |
Analgesics | Â | Â | Â | Â | Â | Â | Â | Â | Â |
 | Fentanyl | Opioid Effects (15)O-water | + |  |  |  |  |  | [167] |
 | Ketamine | NMDA Receptor Binding (n-methyl11C)-ketamine | + | + |  |  |  |  | [168] |